-
The numbers of households with pets are increasing in many countries across the world. In addition, data obtained from media sources note a trend in the percentage of these pets sleeping in, or on, the owner's bed.
-
A randomized, double-blind, placebo-controlled trial of immediate vs. deferred ART in 253 patients with HIV-associated TB meningitis was conducted to determine whether immediate ART reduced the risk of death.
-
A previously healthy 51-year-old man with no history of travel outside of Montana presented to a local emergency department in May 2009 with fever, frontal headache, dizziness, numbness, and tingling.
-
Raltegravir (RAL) received FDA approval in 2007 and is now used in treatment of both treatment-experienced and treatment-naïve patients.
-
A 52-year-old woman had systemic symptoms including nausea and vomiting. Seven months prior to admission she had a subarachnoid hemorrhage and needed multiple ventriculo-pleural shunts.
-
-
In this issue: Two new drugs for treatment of hepatitis C; NSAIDs and myocardial infarction risk; AIM-HIGH clinical trial stopped; and FDA actions.
-
The National Health Service in Britain in 2007 elected to ban traditional white coats and other long-sleeved garments for physicians in the workplace (including long-sleeved blouses and shirts).
-
The Food and Drug Administration (FDA) has issued new draft guidance, "Financial Disclosure by Clinical Investigators, Guidance for Clinical Investigators, Industry, and FDA Staff." The document is now available from FDA's web site at the following link: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM256525.pdf
-
In a prospective observational study, investigators of the HIV-CAUSAL Collaboration evaluated data from participating HIV clinics in Europe as well as in the U.S. Veterans Administration system to determine the optimal CD4+ T cell count at which combination antiretroviral therapy (cART) should be initiated.